Skip to main content

Advertisement

SpringerLink
Log in

Smoking and HIV: Prevalence, Health Risks, and Cessation Strategies

  • Metabolic Complications and Comorbidity (JM Kilby, Section Editor)
  • Published:
Current HIV/AIDS Reports Aims and scope Submit manuscript

Abstract

Health hazards due to smoking may undermine benefits of HIV treatment on morbidity and mortality. Over 40 % of persons with HIV are current smokers. Health risks of smoking include increases in some HIV-associated infections, cardiovascular disease, some cancers, bacterial pneumonia and other lung disease, and overall mortality. Proven strategies for smoking cessation include various counseling approaches, nicotine replacement therapy and other pharmacotherapy; approaches may need to be individualized to address specific client needs and comorbidities. HIV clinicians and other service providers can have an influential role in screening their patients for smoking and promoting cessation programs to improve health.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. CDC. Vital Signs: Current Cigarette Smoking Among Adults Aged ≥18 Years --- United States, 2005--2010. MMWR 2011; 60:1207–12.

  2. • Lifson AR, Neuhaus J, Arribas JR, van den Berg-Wolf M, Labriola AM, Read TR. Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trial. Am J Public Health 2010;100:1896–903. For HIV patients enrolled from 33 countries in a large HIV clinical trial, this reports on the relationship between smoking status and development of AIDS-related or serious non-AIDS events and overall mortality.

    Article  PubMed  Google Scholar 

  3. Tesoriero JM, Gieryic SM, Carrascal A, Lavigne HE. Smoking among HIV-positive New Yorkers: prevalence, frequency, and opportunities for cessation. AIDS Behav. 2010;14:824–35.

    Article  PubMed  Google Scholar 

  4. • Crothers K, Goulet JL, Rodriguez-Barradas MC, et al. Impact of cigarette smoking on mortality in HIV-positive and HIV-negative veterans. AIDS Educ Prev. 2009;21(3 Suppl):40–53. A study evaluating overall mortality in veterans, stratified by HIV and smoking, which concluded that even lower levels of smoking exposure appear to be detrimental in HIV-infected veterans.

    Article  PubMed  Google Scholar 

  5. Benard A, Bonnet F, Tessier JF, et al. Tobacco addiction and HIV infection: toward the implementation of cessation programs. ANRS CO3 Aquitaine Cohort. AIDS Patient Care STDS. 2007;21:458–68.

    Article  PubMed  Google Scholar 

  6. Broom J, Sowden D, Williams M, Taing K, Morwood K, McGill K. Moving from viral suppression to comprehensive patient-centered care: the high prevalence of comorbid conditions and health risk factors in HIV-1-infected patients in Australia. J Int Assoc Physicians AIDS Care. 2012;11:109–14.

    Article  Google Scholar 

  7. • Petoumenos K, Worm S, Reiss P, et al. Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study. HIV Med 2011;12: 412–21. This study concluded that the risk of cardiovascular disease events in HIV-positive patients decreased with increasing time since stopping smoking.

    Article  PubMed  CAS  Google Scholar 

  8. Lloyd-Richardson EE, Stanton CA, Papandonatos GD, et al. HIV-positive smokers considering quitting: differences by race/ethnicity. Am J Health Behav. 2008;32:3–15.

    Article  PubMed  Google Scholar 

  9. Feldman JG, Minkoff H, Schneider MF, et al. Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the Women’s Interagency HIV Study. Am J Public Health. 2006;96:1060–5.

    Article  PubMed  Google Scholar 

  10. World Health Organization. Tobacco. Fact sheet No. 339, July 2011. At: [ www.who.int/mediacentre/factsheets/fs339/en/index.html].

  11. Joint United Nations Programme on HIV/AIDS (UNAIDS). Global report: UNAIDS report on the global AIDS epidemic 2010. [www.unaids.org/globalreport/Global_report.htm].

  12. Kumar SR, Swaminathan S, Flanigan T, Mayer KH, Niaura R. HIV and smoking in India. Indian J Med Res. 2009;130:15–22.

    PubMed  Google Scholar 

  13. Amiya RM, Poudel KC, Poudel-Tandukar K, Kobayashi J, Pandey BD, Jimba M. Physicians are a key to encouraging cessation of smoking among people living with HIV/AIDS: a cross-sectional study in the Kathmandu Valley. Nepal BMC Public Health. 2011;11:677.

    Article  Google Scholar 

  14. Desalu OO, Oluboyo PO, Olokoba AB. et al Prevalence and determinants of tobacco smoking among HIV patients in North Eastern Nigeria. Afr J Med Med Sci. 2009;38:103–8.

    PubMed  CAS  Google Scholar 

  15. Nturibi EM, Kolawole AA, McCurdy SA. Smoking prevalence and tobacco control measures in Kenya, Uganda, the Gambia and Liberia: a review. Int J Tuberc Lung Dis. 2009;13:165–70.

    PubMed  CAS  Google Scholar 

  16. Burns DN, Hillman D, Neaton JD, et al. Cigarette smoking, bacterial pneumonia, and other clinical outcomes in HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13:374–83.

    Article  PubMed  CAS  Google Scholar 

  17. Conley LJ, Bush TJ, Buchbinder SP, Penley KA, Judson FN, Holmberg SD. The association between cigarette smoking and selected HIV-related medical conditions. AIDS. 1996;10:1121–6.

    PubMed  CAS  Google Scholar 

  18. Soysa NS, Ellepola ANB. The impact of cigarette/tobacco smoking on oral candidosis: an overview. Oral Dis. 2005;11:268–73.

    Article  PubMed  CAS  Google Scholar 

  19. Rahmanian S, Wewers ME, Koletar S, Reynolds N, Ferketich A, Diaz P. Cigarette smoking in the HIV-infected population. Proc Am Thorac Soc. 2011;8:313–9.

    Article  PubMed  Google Scholar 

  20. Crothers K, Butt AA, Gibert CL, et al. Increased COPD among HIV-positive compared to HIV-negative veterans. Chest. 2006;130:1326–33.

    Article  PubMed  Google Scholar 

  21. Miguez-Burbano MJ, Ashkin D, Rodriguez A, et al. Increased risk of Pneumocystis carinii and community-acquired pneumonia with tobacco use in HIV disease. Int J Infect Dis. 2005;9:208–17.

    Article  PubMed  Google Scholar 

  22. Crothers K, Griffith TA, McGinnis KA, et al. The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans. J Gen Intern Med. 2005;20:1142–5.

    Article  PubMed  Google Scholar 

  23. World Health Organization. Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings, 2011. At: whqlibdoc.who.int/publications/2011/9789241500708_eng.pdf

  24. Slama K, Chiang CY, Enarson DA, et al. Tobacco and tuberculosis: a qualitative systematic review and meta-analysis. Int J Tuberc Lung Dis. 2007;11:1049–61.

    PubMed  CAS  Google Scholar 

  25. Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, Smith KR. Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch Intern Med. 2007;167:335–42.

    Article  PubMed  Google Scholar 

  26. Van Zyl-Smit RN, Brunet L, Pai M, Yew WW. The convergence of the global smoking, COPD, tuberculosis, HIV, and respiratory infection epidemics. Infect Dis Clin North Am. 2010;24:693–703.

    Article  PubMed  Google Scholar 

  27. Phillips AN, Neaton J, Lundgren JD. The role of HIV in serious diseases other than AIDS. AIDS. 2008;22:2409–18.

    Article  PubMed  Google Scholar 

  28. US Dept of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta, GA: US Dept of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2004.

  29. Barbaro G, Di Lorenzo G, Cirelli A, et al. An open-label, prospective, observational study of the incidence of coronary artery disease in patients with HIV infection receiving highly active antiretroviral therapy. Clin Ther. 2003;25:2405–18.

    Article  PubMed  CAS  Google Scholar 

  30. Friis-Moller N, Sabin CA, Weber R, et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003;349:1993–2003.

    Article  PubMed  Google Scholar 

  31. Grunfeld C, Delaney JA, Wanke C, et al. Pre-clinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM Study. AIDS. 2009;23:1841–9.

    Article  PubMed  Google Scholar 

  32. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370:59–67.

    Article  PubMed  Google Scholar 

  33. Clifford GM, Polesel J, Rickenbach M, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005;97:425–32.

    Article  PubMed  Google Scholar 

  34. Durante AJ, Williams AB, Da Costa M, Darragh TM, Khoshnood K, Palefsky JM. Incidence of anal cytological abnormalities in a cohort of human immunodeficiency virus-infected women. Cancer Epidemiol Biomarkers Prev. 2003;12:638–42.

    PubMed  Google Scholar 

  35. Palefsky JM, Shiboski S, Moss A. Risk factors for anal human papillomavirus infection and anal cytologic abnormalities in HIV-positive and HIV-negative homosexual men. J Acquir Immune Defic Syndr. 1994;7:599–606.

    PubMed  CAS  Google Scholar 

  36. Engels EA, Brock MV, Chen J, Hooker CM, Gillison M, Moore RD. Elevated incidence of lung cancer among HIV-infected individuals. J Clin Oncol. 2006;24:1383–8.

    Article  PubMed  Google Scholar 

  37. Kirk GD, Merlo C. O’ Driscoll P, et al. HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis. 2007;45:103–10.

    Article  PubMed  Google Scholar 

  38. Borderi M, Gibellini D, Vescini F, et al. Metabolic bone disease in HIV infection. AIDS. 2009;23:1297–310.

    Article  PubMed  Google Scholar 

  39. Hansen AB, Gerstoft J, Kronborg G, et al. Incidence of low and high-energy fractures in persons with and without HIV infection: a Danish population-based cohort study. AIDS. 2012;26:285–93.

    Article  PubMed  Google Scholar 

  40. Yin MT, Shi Q, Hoover DR, et al. Fracture incidence in HIV-infected women: results from the Women’s Interagency HIV Study. AIDS. 2010;24:2679–86.

    Article  PubMed  Google Scholar 

  41. Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch Intern Med. 2004;164:2206–16.

    Article  PubMed  Google Scholar 

  42. Grubb JR, Overton ET, Presti R, Onen NF. Reply to Ganesan et al. J Infect Dis. 2012;205:518–9.

    Article  PubMed  Google Scholar 

  43. Deeks SG. HIV infection, inflammation, immunosenescence, and aging. Annual Rev Med. 2011;62:141–55.

    Article  CAS  Google Scholar 

  44. Zanet D, Sattha B, Maan E, et al. HIV infection is marginally associated with shorter leukocyte telomere length [Abstract 307]. 19th Conference of Retroviruses and Opportunistic Infections, Seattle, March 5–8, 2012.

  45. Niaura R, Shadel WG, Morrow K, Tashima K, Flanigan T, Abrams DB. Human immunodeficiency virus infection, AIDS, and smoking cessation: the time is now. Clin Infect Dis. 2000;31:808–12.

    Article  Google Scholar 

  46. Vidrine DJ. Cigarette smoking and HIV/AIDS: health implications, smoker characteristics and cessation strategies. AIDS Educ Prev. 2009;21(3 Suppl):3–13.

    Article  PubMed  Google Scholar 

  47. Vidrine DJ, Arduino RC, Gritz ER. The effects of smoking abstinence on symptom burden and quality of life among persons living with HIV/AIDS. AIDS Patient Care STDS. 2007;21:659–66.

    Article  PubMed  Google Scholar 

  48. Mamary EM, Bahrs D, Martinez S. Cigarette smoking and the desire to quit among individuals living with HIV. AIDS Patient Care STDS. 2002;16:39–42.

    Article  PubMed  Google Scholar 

  49. Prochaska JO, DiClemente CC. Toward a comprehensive model of change. In: Miller WR, Heather N, editors. Treating Addictive Behaviors: Processes of Change. New York: Plenum Press; 1986. p. 3–27.

    Google Scholar 

  50. Burkhalter JE, Springer CM, Chhabra R, Ostroff JS, Rapkin BD. Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nicotine Tob Res. 2005;7:511–22.

    Article  PubMed  Google Scholar 

  51. Humfleet GL, Delucchi K, Kelley K, Hall SM, Dilley J, Harrison G. Characteristics of HIV-positive cigarette smokers: a sample of smokers facing multiple challenges. AIDS Educ Prev. 2009;21(3 Suppl):54–64.

    Article  PubMed  Google Scholar 

  52. • Reynolds NR. Cigarette smoking and HIV: more evidence for action. AIDS Educ Prev 2009; 21(Suppl 3):106–21. This review of factors associated with smoking behavior includes a discussion of social conditions, polysubstance use, psychiatric comorbidities, physical-mental distress, and supporting beliefs, and how a self-regulatory framework relates to smoking behavior.

    Article  PubMed  Google Scholar 

  53. • Nahvi S, Cooperman NA. Review: the need for smoking cessation among HIV-positive smokers. AIDS Educ Prev 2009; 21(Suppl 3):14–27. This paper reviews health consequences of tobacco use in HIV-positive persons and the research to date on smoking cessation interventions in HIV-positive persons.

    Article  PubMed  Google Scholar 

  54. Nicholas PK, Voss JG, Corless IB, et al. Unhealthy behaviours for self-management of HIV-related peripheral neuropathy. AIDS Care. 2007;19:1266–73.

    Article  PubMed  CAS  Google Scholar 

  55. Jamner LD, Girdler SS, Shapiro D, Jarvik ME. Pain inhibition, nicotine, and gender. Exp Clin Psychopharmacol. 1998;6:96–106.

    Article  PubMed  CAS  Google Scholar 

  56. Fiore MC, Jaen CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service. May 2008.

  57. Manley MW, Epps RP, Glynn TJ. The clinician’s role in promoting smoking cessation among clinic patients. Med Clin North Am. 1992;76:477–94.

    PubMed  CAS  Google Scholar 

  58. Hollis JF, Lichtenstein E, Vogt TM, Stevens VJ, Biglan A. Nurse-assisted counseling for smokers in primary care. Ann Intern Med. 1993;118:521–5.

    PubMed  CAS  Google Scholar 

  59. Crothers K, Goulet JL, Rodriguez-Barradas MC, et al. Decreased awareness of current smoking among health care providers of HIV-positive compared to HIV-negative veterans. J Gen Intern Med. 2007;22:749–54.

    Article  PubMed  Google Scholar 

  60. Patwardhan PD, Chewning BA. Ask, advise and refer: hypothesis generation to promote a brief tobacco-cessation intervention in community pharmacies. Int J Pharm Pract. 2009;17:221–9.

    Article  PubMed  Google Scholar 

  61. American Academy of Family Physicians. Tobacco-Use Prevention and Cessation (Position Paper), 2009. At: <www.aafp.org/online/en/home/policy/policies/t/tobaccoprevcess.html>.

  62. National Cancer Institute. Free Help to Quit Smoking. At: <www.cancer.gov/cancertopics/tobacco/smoking>.

  63. North American Quitline Consortium: Promoting Evidence Based Quitline Services Across Diverse Communities in North America. At: <www.naquitline.org>.

  64. Lloyd-Richardson EE, Stanton CA, Papandonatos GD, et al. Motivation and patch treatment for HIV + smokers: a randomized controlled trial. Addiction. 2009;104:1891–900.

    Article  PubMed  Google Scholar 

  65. Ingersoll KS, Cropsey KL, Heckman CJ. A test of motivational plus nicotine replacement interventions for HIV positive smokers. AIDS Behav. 2009;13:545–54.

    Article  PubMed  Google Scholar 

  66. Elzi L, Spoerl D, Voggensperger J, et al. A smoking cessation programme in HIV-infected individuals: a pilot study. Antivir Ther. 2006;11:787–95.

    PubMed  Google Scholar 

  67. Vidrine DJ, Arduino RC, Lazev AB, Gritz ER. A randomized trial of a proactive cellular telephone intervention for smokers living with HIV/AIDS. AIDS. 2006;20:253–60.

    Article  PubMed  Google Scholar 

  68. Pop-Eleches C, Thirumurthy H, Habyarimana JP, et al. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS. 2011;25:825–34.

    Article  PubMed  Google Scholar 

  69. Shahab L, McEwen A. Online support for smoking cessation: a systematic review of the literature. Addiction. 2009;104:1792–804.

    Article  PubMed  Google Scholar 

  70. Muramoto ML, Wassum K, Connolly T, Matthews E, Floden L. Helpers program: A pilot test of brief tobacco intervention training in three corporations. Am J Prev Med. 2010;38(3 Suppl):319–26.

    Article  Google Scholar 

  71. • Mills EJ, Wu P, Spurden D, Ebbert JO, Wilson K. Efficacy of pharmacotherapies for short-term smoking abstinance: a systematic review and meta-analysis. Harm Reduct J 2009;6:25. This is a systematic review and meta-analysis of randomized clinical trials evaluating interventions for smoking abstinence, including nicotine replacement therapy and other pharmacologic agents.

    Article  PubMed  Google Scholar 

  72. Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2008;(1):CD000146.

  73. Swan GE, McAfee T, Curry SJ. at al. Effectiveness of bupropion sustained release for smoking cessation in a health care setting: a randomized trial. Arch Intern Med. 2003;163:2337–44.

    Article  PubMed  CAS  Google Scholar 

  74. Gonzales D, Rennard SI, Nides M, et al. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA. 2006;296:47–55.

    Article  PubMed  CAS  Google Scholar 

  75. Jorenby DE, Hays JT, Rigotti NA, et al. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA. 2006;296:56–63.

    Article  PubMed  CAS  Google Scholar 

  76. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. March 27, 2012; 1–166. At: www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf .

  77. World Health Organization. WHO Report on the Global Tobacco Epidemic, 2008: The MPOWER package. Geneva, World Health Organization, 2008. At: www.who.int/tobacco/mpower/mpower_report_full_2008.pdf.

  78. Centers for Disease Control and Prevention. State smoke-free laws for worksites, restaurants, and bars–United States, 2000–2010. MMWR Morb Mortal Wkly Rep. 2011;60:472–5.

    Google Scholar 

  79. Robinson W, Moody-Thomas S, Gruber D. Patient perspectives on tobacco cessation services for persons living with HIV/AIDS. AIDS Care. 2012;24:71–6.

    Article  PubMed  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Division of Epidemiology and Community Health, University of Minnesota, 1300 S. Second Street, Suite 300, Minneapolis, MN, 55454-1015, USA

    Alan R. Lifson & Harry A. Lando

Authors
  1. Alan R. Lifson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Harry A. Lando
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alan R. Lifson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lifson, A.R., Lando, H.A. Smoking and HIV: Prevalence, Health Risks, and Cessation Strategies. Curr HIV/AIDS Rep 9, 223–230 (2012). https://doi.org/10.1007/s11904-012-0121-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11904-012-0121-0

Keywords

Search

Navigation